Agenus (NASDAQ:AGEN – Get Free Report) and Quantum Genomics Société Anonyme (OTCMKTS:QNNTF – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation. Profitability This table compares Agenus and […]
Agenus (NASDAQ:AGEN – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Analyst Recommendations This is a breakdown of current recommendations and […]
Agenus Inc. (NASDAQ:AGEN – Get Free Report) was the recipient of a large growth in short interest in August. As of August 15th, there was short interest totalling 26,320,000 shares, a growth of 36.2% from the July 31st total of 19,330,000 shares. Based on an average daily trading volume, of 5,290,000 shares, the days-to-cover ratio […]
StockNews.com began coverage on shares of Agenus (NASDAQ:AGEN – Free Report) in a report released on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Other analysts have also issued research reports about the company. Robert W. Baird assumed coverage on Agenus in a report on Monday, June 5th. They set […]
StockNews.com started coverage on shares of Agenus (NASDAQ:AGEN – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Several other brokerages have also commented on AGEN. HC Wainwright reiterated a buy rating and issued a $8.00 price target on shares of Agenus in a […]